Microglia in amyotrophic lateral sclerosis

Acta Neurologica Belgica

Volumn 107, Issue 3, 2007, Pages 63-70

  Dewil, Maarten ^a,b   Van Den Bosch, Ludo ^a   Robberecht, Wim ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Division of Gastroenterology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CELECOXIB; COPPER ZINC SUPEROXIDE DISMUTASE; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NIMESULIDE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL ACTIVATION; CELL POPULATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEATH; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; HUMAN; HYPOTHESIS; INFLAMMATION; MICROGLIA; MOTONEURON; NERVE CELL NECROSIS; NERVE FIBER TRANSPORT; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; RECEPTOR UPREGULATION; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 36148979040     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. AKERLUND K., ERLANDSSON HARRIS H., TRACEY K. J., WANG H., FEHNIGER T., KLARESKOG L., ANDERSON J., ANDERSON U. Anti-inflmmatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collageninduced arthritis (CIA) in rats. Clin. Exp. Immunol., 1999,115: 32-41.
2. ALEXIANU M. E., KOZOVSKA M., APPEL S. H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology, 2001, 57: 1282-1289.
3. ALLIOT F., GODIN I., PESSAC B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res., 1999, 117: 145-152.
4. ALMER G., VUKOSAVIC S., ROMERO N., PRZEDBORSKI S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 1999, 72: 2415-2425.
5. ANDERSEN P. M. Genetics of sporadic ALS.Amyotroph Lateral Scler. Other Motor Neuron Disord., 2001, 2 (Suppl. 1): S37-41.
6. ASAHI M., ASAHI K., JUNG J. C., DEL ZOPPO G. J., FINI M. E., LO E. H. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab., 2000, 20: 1681 -1689.
7. BANATI R. B., MYERS R., KREUTZBERG G. W. PK ('peripheral benzodiazepine') - binding sites in the CNS indicate early and discrete brain lesions: Microautoradiographic detection of [3H]PKI 11195 binding to activated microglia. J. Neurocytol., 1997, 26: 77-82.
8. BEERS D. R., HENKEL J. S., XIAO Q., ZHAO W., WANG J., YEN A.A., SIKLOS L., MCKERCHER S. R., APPEL S. H. Wild-type microglia extend survival in PU. 1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA, 2006, 103: 16021-16026.
9. BESSIS A., BECHADE C., BERNARD D., ROUMIER A. Microglial control of neuronal death and synaptic properties. Glia, 2006.
10. BEUCHE W., YUSHCHENKO M., MADER M., MALISZEWSKA M., FELGENHAUER K., WEBER F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport, 2000, 11: 3419-3422.
11. BLOCK M. L., HONG J. S. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog. Neurobiol., 2005, 76: 77-98.
12. BOILLEE S., VANDE VELDE C., CLEVELAND D. W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron, 2006a, 52: 39-59.
13. BOILLEE S., YAMANAKA K., LOBSIGER C. S., COPELAND N. G., JENKINS N. A., KASSIOTIS G., KOLLIAS G., CLEVELAND D. W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 2006b, 312: 1389-1392.
14. BROWN R. H., JR., ROBBERECHT W. Amyotrophic lateral sclerosis: pathogenesis. Semin. Neurol., 2001, 21: 131-139.
15. BRUIJN L. I., MiLLER T. M., CLEVELAND D. W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 2004, 27: 723-749.
16. CHEN Y. Z., BENNETT C. L., HUYNH H. M., BLAIR I. P., PULS I., IROBI J., DIERICK I., ABEL A., KENNERSON M. L., RABIN B. A., NICHOLSON G. A., AUER-GRUMBACH M., WAGNER K., DE JONGHE P., GRIFFIN J. W., FISCHBECK K. H., TIMMERMAN V., CORNBLATH D. R., CHANCE P. F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet., 2004, 74: 1128-1135.
17. CLEMENT A. M., NGUYEN M. D., ROBERTS E. A., GARCIA M. L., BOILLEE S., RULE M., MCMAHON A. P., DOUCETTE W., SIWEK D., FERRANTE R. J., BROWN R. H., Jr., JULIEN J. P., GOLDSTEIN L. S., CLEVELAND D. W. Wild-type non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 2003, 302: 113-117.
18. CLEVELAND D. W., ROTHSTEIN J. D. From charcot to lou gehrig: deciphering selective motor neuron death in als. Nat. Rev. Neurosci., 2001, 2: 806-819.
19. CUADROS M. A., NAVASCUES J. The origin and differentiation of microglial cells during development. Prog. Neurobiol., 1998, 56: 173-189.
20. DAVALOS D., GRUTZENDLER J., YANG G., KIM J. V., Zuo Y., JUNG S., LITTMAN D. R., DUSTIN M. L., GAN W. B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci., 2005, 8: 752-758.
21. DENHAM W., YANG J., WANG H., BOTCHKINA G., TRACEY K. J., NORMAN J. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit. Care Med., 2000, 28: 2567-2572.
22. DEWIL M., DELA CRuz V. F., VAN DEN BOSCH L., ROBBERECHT W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis., 2007a, 26: 332-341.
23. DEWIL M., LAMBRECHTS D., SCIOT R., SHAW P. J., INCE P. G., ROBBERECHT W., VAN DEN BOSCH L. VEGF counteracts the loss of the phospho-Akt preceding motor neuron death in ALS. J. Neuropathol. Exp. Neurol., 2007b, in press.
24. DEWIL M., SCHURMANS C., STARCKX S., OPDENAKKER G., VAN DEN BOSCH L., ROBBERECHT W. Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis. Neuroreport, 2005, 16 321-324.
25. DEWEL M., VAN WUMEERSCH B., PHILIPS T., BILLIAU A., WAER M., VAN DEN BOSCH L., ROBBERECHT W. Functional characterisation of microglial activation in ALS: Contribution of myeloid precursor cells. 2007c, submitted.
26. DRACHMAN D. B., FRANK K., DYKES-HOBERG M., TEISMANN P., ALMER G., PRZEDBORSKI S., ROTHSTEIN J. D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol., 2002, 52: 771-778.
27. EIKELENBOOM P., BATE C., VAN GOOL W. A., HOOZEMANS J. J., ROZEMULLER J. M., VEERHUIS R., WILLIAMS A. Neuroinflammation in Alzheimer's disease and prion disease. Glia, 2002, 40: 232-239.
28. ELLIOTT J. L. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res., 2001, 95: 172-178.
29. FERRI A., NENCIN1 M., CASCIATI A., COZZOLINO M., ANGELINI D. F., LONGONE P., SPALLONI A., ROTILIO G., CARRI M. T. Cell death in amyotrophic lateral sclerosis: Interplay between neuronal and glial cells. Faseb. J., 2004, 18: 1261-1263.
30. FISCHER L. R., CULVER D. G., TENNANT P., DAVIS A. A., WANG M., CASTELLANO-SANcHEz A., KHAN J., POLAK M. A., GLASS J. D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol., 2004, 185: 232-240.
31. GAO H. M., JIANG J., WILSON B., ZHANG W., HONG J. S., LIU B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J. Neurochem., 2002, 81: 1285-1297.
32. GARBUZOVA-DAVIS S., HALLER E., SAPORTA S., KOLOMEY I., NICOSIA S. V., SANBERG P. R. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SODI mice modeling ALS. Brain Res., 2007, 1157: 126-137.
33. GARDEN G. A. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia, 2002, 40: 240-251.
34. GIULIAN D., HAVERKAMP L. J., YU J. H., KARSHIN W., Tom D., LI J., KIRKPATRICK J., KUO L. M., ROHER A. E. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci., 1996, 16: 6021-6037.
35. GONG Y. H., PARSADANIAN A. S., ANDREEVA A., SNIDER W. D., ELLIOTT J. L. Restricted expression of, G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci., 2000, 20: 660-665.
36. GOWING G., DEQUEN F., SOUCY G., JULIEN J. P. Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations. J. Neurosci., 2006, 26: 11397-11402.
37. GRUZMAN A., WOOD W. L., ALPERT E., PRASAD M. D., MILLER R. G., ROTHSTEIN J. D., BOWSER R., HAMILTON R., WOOD T. D., CLEVELAND D. W., LINGAPPA V. R., LIU J. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA, 2007, 104: 12524-12529.
38. GURNEY M. E., PU H., CHIU A. Y., DAL CANTO M. C., POLCHOW C. Y., ALEXANDER D. D., CALIENDO J., HENTATI A., KWON Y W., DENG H. X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 1994, 264: 1772-1775.
39. HADANO S., HAND C. K., OSUGA H., YANAGISAWA Y., OTOMO A., DEVON R. S., MIYAMOTO N., SHOWGUCHI-MIYATA J., OKADA Y., SiNGARAJA R., FIGLEWICZ D. A., KWIATKOWSKI T., HOSLER B. A., SAGiE T., SKAUG J., NASIR J., BROWN R.H., Jr., SCHERER S.W., ROULEAU G.A., HAYDEN M. R., IKEDA J. E. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet., 2001, 29: 166-173.
40. HALL E. D., OOSTVEEN J. A., GURNEY M. E. Relationship of microglial and astrocytic: Activation to disease onset and progression in a transgenic model of familial ALS. Glia, 1998, 23: 249-256.
41. HENKEL J. S., ENGELHARDT J. I., SiKLOS L., SIMPSON E. P., KIM S. H., PAN T., GOODMAN J. C., SIDDIQUE T., BEERS D. R., APPEL S. H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol., 2004, 55: 221-235.
42. HENSLEY K., FEDYNYSHYN J., FERRELL S., FLOYD R. A., GORDON B., GRAMMAS P., HAMDHEYDARI L., MHATRE M., MOU S., PYE Q. N., STEWART C., WEST M., WEST S., WILLIAMSON K. S. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis., 2003, 14: 74-80.
43. HENSLEY K., FLOYD R. A., GORDON B., MOU S., PYE Q. N., STEWART C., WEST M., WILLIAMSON K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem., 2002, 82: 365-374.
44. HOMMES D., VAN DEN BLINK B., PLASSE T., BARTELSMAN J., XU C., MACPHERSON B., TYTGAT G., PEPPELENBOSCH M., VAN DEVENTER S. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology, 2002, 122: 7-14.
45. JAARSMA D. Neuron-specific expression of mutant SOD1 protein is sufficient to cause motor neuron disease in mice. 4th European ALS Consortium Research Workshop, Utrecht, Abstract 025, 2006.
46. JOHANSSON A., ENGLER H., BLOMQUIST G., SCOTT B., WALL A., AQUILONIUS S. M., LANGSTROM B., ASKMARK H. Evidence for astrocytosis in ALS demonstrated by [(11)C](1)-deprenyl-D2 PET. J. Neurol. Sci., 2007, 255: 17-22.
47. KAWAMATA T., AKIYAMA H., YAMADA T., MCGEER P. L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol., 1992, 140: 691-707.
48. KIAEI M., KIPIANI K., CALiNGASAN N. Y., WILLE E., CHEN J., HEISSIG B., RAFII S., LORENZL S., BEAL M. F. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol., 2007, 205: 74-81.
49. KIAEI M., PETRI S., KIPIANI K., GARDIAN G., CHOI D. K., CHEN J., CALINGASAN N. Y., SCHAFER P., MULLER G. W., STEWART C., HENSLEY K., BEAL M. F. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic: Lateral sclerosis. J. Neurosci., 2006, 26: 2467-2473.
50. KIM W. G., MOHNEY R. P., WILSON B., JEOHN G. H., LIU B., HONG J. S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J. Neurosci., 2000, 20: 6309-6316.
51. KLVENYI R, KIAEI M., GARDIAN G., CALINGASAN N. Y., BEAL M. F. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem., 2004, 88: 576-582.
52. KOISTiNAHO M., KOISTiNAHo J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia, 2002, 40: 175-183.
53. KRIZ J., NGUYEN M. D., JULIEN J. P. Minocycline slows disease progression in a, mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis., 2002, 10: 268-278.
54. LINO M. M., SCHNEIDER C., CARONI P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci., 2002, 22: 4825-4832.
55. LIU B., HONG J. S. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther., 2003, 304: 1-7.
56. LORENZL S., ALBERS D. S., RELKIN N., NGYUEN T., HILGENBERG S. L., CHIRICHIGNO J., CUDKOWICZ M. E., BEAL M. F. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int., 2003, 43: 191-196.
57. LORENZL S., NARR S., ANGELE B., KRELL H. W., GREGORIO J., KIAEI M., PFISTER H. W., BEAL M. F. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. Exp. Neurol., 2006, 200: 166-171.
58. LUKES A., MUN-BRYCE S., LUKES M., ROSENBERG G. A. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol., 1999, 19: 267-284.
59. MAJOOR-KRAKAUER D., WILLEMS P. J., HOFMAN A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet., 2003, 63: 83-101.
60. MiNGHETTI L., LEVI G. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog. Neurobiol., 1998, 54: 99-125.
61. MOORE S., THANOS S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol., 1996, 48: 441-460.
62. NAKAMURA Y. Regulating factors for microglial activation. Biol. Pharm. Bull., 2002, 25: 945-953.
63. NGUYEN M. D., D'AIGLE T., GOWING G., JULIEN J. P., RIVEST S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci., 2004, 24: 1340-1349.
64. NGUYEN M. D., JULIEN J. P., RIVEST S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin-1 beta in neurodegeneration. Ann. Neurol., 2001, 50: 630-639.
65. NIMMERJAHN A., KIRCHHOFF F, HELMCHEN F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308: 1314-1318.
66. NISHIMURA A. L., MITNE-NETO M., SILVA H. C., RICHIERI-COSTA A., MIDDLETON S., CASCIO D., KOK F., OLIVEIRA J. R., GILLINGWATER T., WEBB J., SKEHEL P., ZATZ M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 2004, 75: 822-831.
67. PASINELLi P., BROWN R. H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci., 2006, 7: 710-723.
68. POLONI M., FACCHETTI D., MAI R., MICHELI A., AGNOLETTI L., FRANCOLINI G., MORA G., CAMANA C., MAZZINI L., BACHETTI T. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett., 2000, 287: 211-214.
69. POWL P. N., HO L., BIANCHI M., MCMANUS T., QIN W., PASINETTI G. M. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Faseb. J., 2003, 17: 725-727.
70. PRAMATAROVA A., LAGANIERE J., ROUSSEL J., BR1SEBOIS K., ROULEAU G. A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci., 2001, 21: 3369-3374.
71. PREWITT C. M., NIESMAN 1. R., KANE C. J., HOULE J. D. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp. Neurol., 1997, 148: 433-443.
72. RAIVICH G., JONES L. L., KLOSS C. U., WERNER A., NEUMANN H., KREUTZBERG G. W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci., 1998, 18: 5804-5816.
73. RAPALINO O., LAZAROV-SPIEGLER O., AGRANOV E., VELAN G. J., YOLES E., FRAIDAKIS M., SOLOMON A., GEPSTEiN R., KATZ A., BELKIN M., HADANI M., SCHWARTZ M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med., 1998, 4: 814-821.
74. ROBBERECHT W. Genetic markers of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord., 2000, 1 (Suppl. 2): S57-59.
75. ROGERS J., STROHMEYER R., KOVELOWSKi C. J., LI R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia, 2002, 40:260-269.
76. ROSEN D. R., SIDDIQUE T., PATTERSON D., FIGLEWICZ D. A., SAPP P., HENTATI A., DONALDSON D., GOTO J., O'REGAN J. P., DENG H. X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362: 59-62.
77. SAGOT Y., DOBOIS-DAUPHIN M., TAN S. A., DE BILBAO F., AEBISCHER P., MARTINOU J. C., KATO A. C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci., 1995, 15: 7727-7733.
78. STREIT W. J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res., 2004, 77: 1-8.
79. TIKKA T., FIEBICH B. L., GOLDSTEINS G., KEINANEN R., KOISTINAHO J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci., 2001, 21: 2580-2588.
80. TIKKA T. M., KOISTINAHo J. E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol., 2001, 166: 7527-7533.
81. TORTAROLO M., VEGLIANESE P., CALVARESI N., BOTTURI A., ROSSI C., GIORGINI A., MIGHELI A., BENDOTTI C. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci., 2003, 23: 180-192.
82. TURNER M. R., CAGNIN A., TURKHEIMER F. E., MILLER C. C., SHAW C. E., BROOKS D. J., LEIGH P. N., BANATi R. B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11CI(R)-PK11195 positron emission tomography study. Neurobiol. Dis., 2004, 15: 601-609.
83. URUSHITANI M., SIK A., SAKURAI T., NUKINA N., TAKAHASHI R., JULIEN J. P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci., 2006, 9: 108-118.
84. VAN DAMME P., DEWIL M., ROBBERECHT W., VAN DEN BOSCH L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener Dis., 2005, 2: 147-159.
85. VAN DEN BOSCH L., TILKIN P., LEMMENS G., ROBBERECHT W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport, 2002, 13: 1067-1070.
86. VAN DEN BOSCH L., TIMMERMAN V. Genetics of motor neuron disease. Curr Neurol. Neurosci. Rep., 2006, 6: 423-431.
87. WEYDT P., YUEN E. C., RANSOM B. R., MOLLER T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia, 2004, 48: 179-182.
88. YANG Y., HENTATI A., DENG H. X., DABBAGH O., SASAKI T., HIRRANO M., HUNG W. Y., OUAHCHI K., YAN J., AZIM A. C., COLE N., GASCON G., YAGMOUR A., BEN-HAMIDA M., PERICAK-VANCE M., HENTATI F., SIDDIQUE T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet., 2001, 29: 160-165.
89. YONG V. W., POWER C., FORSYTH R, EDWARDS D. R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci., 2001, 2: 502-511.
90. YOSHIHARA T., ISHIGAM S., YAMAMOTO M., LIANG Y., NIWA J., TAKEUCHI H., DOYU M., SOBUE G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 2002, 80: 158-167.
91. ZHU S., STAVROVSKAYA I. G., DROZDA M., KIM B.Y., ONA V., LI M., SARANG S., LIU A.S., HARTLEY D. M., WU DU C., GULLANS S., FERRANTE R. J., PRZEDBORSKI S., KRISTAL B. S., FRIEDLANDER R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 2002, 417: 74-78.